Home > Healthcare > Medical Devices > Therapeutic Devices > Balloon Valvuloplasty Devices Market

Balloon Valvuloplasty Devices Market Share

Report ID: GMI9540
Published Date: May 2024
Report Format: PDF

Download Free Sample

Balloon Valvuloplasty Devices Market Share

The balloon valvuloplasty devices industry is highly competitive, marked by several players striving for market dominance. Providers offer comprehensive devices with improved efficiency and affordability. This includes advancements in reading, raw material, data reporting, sensor design, and customization. Competition is driven by factors such as the quality, reliability, performance, cost, and compliance with regulatory standards. Strategic partnerships with companies and healthcare networks play a crucial role in market positioning.

Balloon Valvuloplasty Devices Market Companies

Some of the eminent market participants operating in the balloon valvuloplasty devices industry include:

Abbott Laboratories
B. Braun Melsungen AG
Becton, Dickinson, and Company
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Medical Inc.
Edwards Lifesciences Corporation
Innomed Medical Development Ltd.
Jotech GmbH
Medtronic plc
Microport Scientific Corporation
Numed Canada Inc.
NuMED Inc.
Osypka Medical GmbH
Teleflex Incorporated

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Market size for balloon valvuloplasty devices was valued at USD 2.4 billion in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032, driven by rising geriatric population.

The standard balloon product type segment in the balloon valvuloplasty devices industry is estimated to record USD 1.5 billion by the end of 2032, owing to their versatility and utility in a variety of valvuloplasty procedures.

U.S. balloon valvuloplasty devices market held a decent growth rate in 2023 and will grow at 4.4% CAGR during 2024-2032, owing to the high prevalence of valvular heart disease, such as aortic stenosis and mitral stenosis, due to an aging population and lifestyle-related risk.

Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson, and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical Inc., Edwards Lifesciences Corporation, Innomed Medical Development Ltd., Jotech GmbH, and Medtronic plc among others.